Search results for "Row"

showing 10 items of 9311 documents

Teprotumumab for Thyroid-Associated Ophthalmopathy

2017

Thyroid-associated ophthalmopathy, a condition commonly associated with Graves' disease, remains inadequately treated. Current medical therapies, which primarily consist of glucocorticoids, have limited efficacy and present safety concerns. Inhibition of the insulin-like growth factor I receptor (IGF-IR) is a new therapeutic strategy to attenuate the underlying autoimmune pathogenesis of ophthalmopathy.We conducted a multicenter, double-masked, randomized, placebo-controlled trial to determine the efficacy and safety of teprotumumab, a human monoclonal antibody inhibitor of IGF-IR, in patients with active, moderate-to-severe ophthalmopathy. A total of 88 patients were randomly assigned to r…

AdultMalemedicine.medical_specialty030209 endocrinology & metabolismDiseaseAdult; Aged; Antibodies Monoclonal; Diabetes Complications; Double-Blind Method; Exophthalmos; Female; Graves Ophthalmopathy; Humans; Hyperglycemia; Immunologic Factors; Insulin-Like Growth Factor I; Intention to Treat Analysis; Logistic Models; Male; Middle Aged; Quality of LifeAntibodies Monoclonal HumanizedPlaceboAntibodiesReceptor IGF Type 1law.inventionDiabetes ComplicationsGraves' ophthalmopathy03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallawInternal medicineMonoclonalmedicineClinical endpointExophthalmosHumansImmunologic FactorsInsulin-Like Growth Factor IAgedIntention-to-treat analysisTeprotumumabbusiness.industryAntibodies MonoclonalGeneral MedicineMiddle Agedmedicine.diseaseIntention to Treat AnalysisGraves OphthalmopathyLogistic ModelsHyperglycemiaMonoclonalImmunologyQuality of Life030221 ophthalmology & optometryFemalebusinessmedicine.drugNew England Journal of Medicine
researchProduct

Management of intralabyrinthine schwannomas

2006

Abstract Objectives Our protocol to manage the intralabyrinthine schwannoma (ILS). Methods Retrospective chart review of 7 consecutive patients managed for ILS. Results Five patients underwent surgical removal of the lesions and none experienced significant complications or recurrent disease. One patient refused surgical treatment and was closely followed by serial MRI scans with no signs of tumor growth. One patient is presently managed conservatively due to a good hearing. Conclusions Diagnosis of ILS is based on high resolution MRI scans and should be included in the differential diagnosis of patients investigated for cochleovestibular symptoms. Treatment modality of ILS is controversial…

AdultMalemedicine.medical_specialtyAcoustic neurinomaHearing lossLabyrinth DiseasesInner ear tumorPostoperative ComplicationsVestibular schwannomaOlder patientsVertigootorhinolaryngologic diseasesRecurrent diseaseHumansMedicineIntralabyrinthine schwannomaTumor growthIntralabyrinthine schwannomaEar NeoplasmsMeniere DiseaseRetrospective Studiesbiologybusiness.industryNeuroma AcousticGeneral MedicineMiddle Agedbiology.organism_classificationMagnetic Resonance ImagingSurgeryTreatment OutcomeOtorhinolaryngologyTreatment modalityEar InnerAudiometry Pure-ToneFemaleSurgeryDifferential diagnosismedicine.symptomAudiometry SpeechbusinessAuris Nasus Larynx
researchProduct

Arrhythmia profile in acromegaly.

1992

In a controlled study, the cardiac involvement and arrhythmia profile of 32 patients with acromegaly were correlated with endocrine parameters (somatomedine C, growth hormone), clinical score and duration of the disease. Data were compared with those of 50 controls free of cardiac disease. Stress ECG, 24 h Holter monitoring and echocardiography were performed. Supraventricular premature complexes occurred no more often in acromegalics than in controls. Both prevalence and severity of ventricular arrhythmia, however, were significantly higher in patients compared to controls (P less than 0.01). 15/32 (48%) acromegalic patients had complex ventricular arrhythmias (Lown III-IV) as compared wit…

AdultMalemedicine.medical_specialtyAdenomaConcentric hypertrophyLeft ventricular hypertrophyElectrocardiographyInternal medicineAcromegalymedicineHumanscardiovascular diseasesAgedmedicine.diagnostic_testbusiness.industryArrhythmias CardiacHeartMiddle Agedmedicine.diseaseEndocrinologyEchocardiographyGrowth HormoneAmbulatoryAcromegalycardiovascular systemCardiologyExercise TestFemaleCardiology and Cardiovascular MedicinebusinessComplicationElectrocardiographyHormoneEuropean heart journal
researchProduct

Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collag…

2004

To verify whether combined measurements of GH-dependent parameters might be useful in detecting exogenous recombinant GH (rGH) administration in male athletes from different disciplines.Sixty-six athletes (control group) were sampled for the evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and telopeptide type I collagen (ICTP). Cut-off values (mean + 2 SD) for IGF-I, PIIINP and ICTP were calculated and arbitrary scores (1.5, 2.0) were assigned to abnormal parameters. By using the sum of individual parameter scores, positive (or = 3) or negative (3) scores were obtained. In addition, a subgroup of six athletes was treated for 3 weeks with rGH (0.09 IU/kg b…

AdultMalemedicine.medical_specialtyAdolescentEndocrinology Diabetes and MetabolismRhgh treatmentSensitivity and SpecificityCollagen Type IEndocrinologyN-terminal telopeptidePreliminary reportInternal medicinemedicineHumansInsulin-Like Growth Factor IDoping in Sportsbiologybusiness.industryAthletesN terminal propeptidebiology.organism_classificationPeptide FragmentsType III ProcollagenProcollagen peptidaseEndocrinologyCase-Control StudiesGrowth HormonebusinessPeptidesType I collagenBiomarkersProcollagenSportsClinical endocrinology
researchProduct

Prenatal Exposure to NO2 and Ultrasound Measures of Fetal Growth in the Spanish INMA Cohort

2016

This study was funded by grants from the European Union: NEWGENERIS FP6-2003- Food-3-A-016320, FP7-ENV-2011 cod 282957, HEALTH.2010.2.4.5-1; and by grants from Spain: Instituto de Salud Carlos III (Red INMA G03/176, CB06/02/0031, and FIS-FEDER PI03/1615, PI04/1509, PI04/1112, PI04/1931, PI04/2018, PI04/1436, PI05/1079, PI05/1052, PI06/1213, PI07/0314, PI08/1151, PI09/02647, PI09/02311, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/02429, PI14/0891, PI14/1687, and Miguel Servet CP11/00178 and MS13/00054), Conselleria de Sanitat Generalitat Valenciana, Generalitat de Catalunya (CIRIT 1999SGR 00241), Diputación Foral de Guipúzcoa (DFG/004), Departamento de Sanidad y Consumo Gobierno Vasc…

AdultMalemedicine.medical_specialtyAdolescentHealth Toxicology and MutagenesisNitrogen DioxideEmbaràsMEDLINE010501 environmental sciences01 natural sciencesUltrasonography PrenatalCohort StudiesFetal DevelopmentYoung Adult03 medical and health sciences0302 clinical medicinePregnancyFetal growthHumansMedicine030212 general & internal medicineYoung adult0105 earth and related environmental sciencesAir PollutantsPregnancyAnthropometrybusiness.industryObstetricsAire -- ContaminacióUltrasoundPublic Health Environmental and Occupational HealthAnthropometrymedicine.disease3. Good healthMaternal ExposureSpainChildren's Healthembryonic structuresCohortFemalebusinessCohort study
researchProduct

Endocrine Response Patterns to Acute Unilateral and Bilateral Resistance Exercise in Men

2009

Rehabilitation programs and research experiments use single-arm protocols in which the contralateral arm is not functional or used as a control limb. This study was interested in determining the hormonal signal impacts of such one- versus two-arm exercise responses that might have an impact on adaptational changes with training. The purpose was to examine the acute hormonal responses to a unilateral and a bilateral upper-body resistance exercise (RE) protocol. A balanced randomized treatment intervention with series time frame for blood collections before and after exercise was used as the basic experimental design. Ten recreationally resistance trained men (18-25 years, 20.4 +/- 1.2 years,…

AdultMalemedicine.medical_specialtyAdolescentHydrocortisonemedicine.medical_treatmentPhysical ExertionPhysical Therapy Sports Therapy and RehabilitationHematocritlaw.inventionHemoglobinsYoung AdultRandomized controlled triallawInternal medicinemedicineHumansInsulinEndocrine systemTestosteroneOrthopedics and Sports MedicineYoung adultTestosteroneRehabilitationmedicine.diagnostic_testHuman Growth HormoneInsulinResistance TrainingGeneral MedicineEndocrinologyHematocritAnesthesiaArmLactatesPsychologyHormoneJournal of Strength and Conditioning Research
researchProduct

Confirmatory factor analysis and psychometric properties of the Yale–Brown–Cornell Eating Disorders Scale Self-Report version (SR-YBC-EDS) in Spanish…

2015

[EN] Objective: The aimof the study was to adapt and validate the Yale Brown Cornell Eating Disorder Scale (YBC-EDS) transformed into a self-report format in Spanish clinical and non-clinical samples. Method: Eighty-three eating disordered patients and 358 non-clinical participants completed the Self Report-YBCEDS version (SR-YBC-EDS), the Eating Attitudes Test (EAT), and the Penn State Worry Questionnaire (PSWQ). Results: Confirmatory factor analyses of a two-factor second-order model showed adequate values of goodness-of fit indices for non-clinical (normed ÷2=13.4578; df=18; NFI=0.980; GFI=1.00; RMSEA= 0.00) and clinical samples (normed ÷2 = 26.5913; df =18; NFI = 0.944; GFI = 0.981; RMS…

AdultMalemedicine.medical_specialtyAdolescentPsychometricsPsychometricsESTADISTICA E INVESTIGACION OPERATIVAFeeding and Eating DisordersYoung AdultCronbach's alphaPositive predicative valuemedicineHumansPsychiatryLanguagePsychiatric Status Rating ScalesConfirmatory Factor AnalisysReproducibility of Resultsmedicine.diseaseConfirmatory factor analysisPsychiatry and Mental healthClinical PsychologyEating disordersConvergent validityScale (social sciences)Yale Brown Cornell Eating Disorder ScaleEating Attitudes TestFemaleSelf ReportFactor Analysis StatisticalPsychologySelf-reportClinical and non-clinical samplesEating Behaviors
researchProduct

Intragenic KANSL1 mutations and chromosome 17q21.31 deletions: broadening the clinical spectrum and genotype-phenotype correlations in a large cohort…

2015

Background The 17q21.31 deletion syndrome phenotype can be caused by either chromosome deletions or point mutations in the KANSL1 gene. To date, about 60 subjects with chromosome deletion and 4 subjects with point mutation in KANSL1 have been reported. Prevalence of chromosome deletions compared with point mutations, genotype–phenotype correlations and phenotypic variability have yet to be fully clarified. Methods We report genotype–phenotype correlations in 27 novel subjects with 17q21.31 deletion and in 5 subjects with KANSL1 point mutation , 3 of whom were not previously reported. Results The prevalence of chromosome deletion and KANSL1 mutation was 83% and 17%, respectively. All patient…

AdultMalemedicine.medical_specialtyAdolescentgenotype-phenotype correlationsKoolen De Vries syndromeKANSL1 mutationHaploinsufficiencyBiologySettore MED/03 - GENETICA MEDICASeverity of Illness IndexCraniofacial AbnormalitiesYoung AdultSeizuresMolecular geneticsGeneticsmedicineHumansAbnormalities MultipleLanguage Development DisordersChildGenetics (clinical)Genetic Association StudiesGeneticsOptic nerve hypoplasiaFetal Growth RetardationPoint mutationMacrocephalyInfantNuclear ProteinsSyndromeclinical heterogeneitySmith–Magenis syndromemedicine.diseaseChild PreschoolSpeech delayFemalemedicine.symptomChromosome DeletionSmith-Magenis SyndromeHaploinsufficiencyChromosomes Human Pair 1717q21.31 deletion
researchProduct

Effects of prolonged hypertrophic resistance training on acute endocrine responses in young and older men.

2015

The present study investigated changes in acute serum hormone responses to a resistance exercise bout following a prolonged period of hypertrophic resistance training in young (YM) and older men (OM). Subjects performed a 5 × 10RM leg press exercise protocol before and after 20 weeks of hypertrophic resistance training. In YM, the acute responses in growth hormone were greater compared with before training (p < .05), and cortisol concentration did not increase after training. Endocrine responses in OM were similar before and after training. Greater acute growth hormone responses after training were associated with larger gains in lean mass in the entire subject group (r = .596, p = .019)…

AdultMalemedicine.medical_specialtyAgingHydrocortisoneSubject groupPhysical Therapy Sports Therapy and RehabilitationGrowth hormoneStatistics NonparametricCohort StudiesInternal medicineEndocrine systemMedicineHumansTestosteroneLeg pressMuscle SkeletalTestosteroneAgedbusiness.industryHuman Growth HormoneRehabilitationResistance trainingAge FactorsResistance TrainingHypertrophyMiddle AgedAdaptation PhysiologicalEndocrinologyLean body massGeriatrics and GerontologybusinessGerontologyBlood Chemical AnalysisHormoneJournal of aging and physical activity
researchProduct

Effects of heavy-resistance training on hormonal response patterns in younger vs. older men.

1999

To examine the adaptations of the endocrine system to heavy-resistance training in younger vs. older men, two groups of men (30 and 62 yr old) participated in a 10-wk periodized strength-power training program. Blood was obtained before, immediately after, and 5, 15, and 30 min after exercise at rest before and after training and at rest at −3, 0, 6, and 10 wk for analysis of total testosterone, free testosterone, cortisol, growth hormone, lactate, and ACTH analysis. Resting values for insulin-like growth factor (IGF)-I and IGF-binding protein-3 were determined before and after training. A heavy-resistance exercise test was used to evaluate the exercise-induced responses (4 sets of 10-repe…

AdultMalemedicine.medical_specialtyAgingHydrocortisoneWeight LiftingPhysiologyPhysical exerciseSquatAdrenocorticotropic hormoneHematocritAdrenocorticotropic HormonePhysiology (medical)Internal medicinemedicineHumansTestosteroneInsulin-Like Growth Factor IMuscle SkeletalHydrocortisonemedicine.diagnostic_testbusiness.industryHuman Growth HormoneTestosterone (patch)Middle Agedmedicine.diseaseHormonesEndocrinologyInsulin-Like Growth Factor Binding Protein 3HematocritPhysical FitnessSarcopeniaBody CompositionbusinessHormonemedicine.drugJournal of applied physiology (Bethesda, Md. : 1985)
researchProduct